A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00389051
Recruitment Status : Completed
First Posted : October 17, 2006
Last Update Posted : August 21, 2007
Information provided by:
SymBio Pharmaceuticals